Experts agree that combination approaches, which may or may not include chemotherapy, will drive improved patient outcomes in ...

Enrollment continues to progress in Phase 3 AURORA trial of Descartes-08 in myasthenia gravisPhase 2 TRITON trial of Descartes-08 in ...

Post-treatment lung health is a longitudinal survivorship issue; nonregenerative parenchymal loss, radiation fibrosis, and ...

Novo Nordisk (NVO) stock is in focus as FDA declines a cancer drug approval for Incyte (INCY) and MacroGenics (MGNX) due to ...

Independently developed by Junshi Biosciences, JS001sc injection is a subcutaneous injection based on the marketed product toripalimab injection (code: JS001) that is expected to enhance convenience ...

Trump had used a 1974 law to impose a 10% tariff on most products worldwide. On Wednesday, that rate went up to 15% ...

Advancing a selective oral NMDA receptor modulator toward Phase 2a in chemotherapy-induced peripheral neuropathy following favorable Phase 1 safety and tolerability findings ...

Meanwhile, prescriptions for an unproven autism treatment soared after a widely watched September press conference by Trump ...

After President Trump told pregnant women not to take Tylenol, orders for it declined among pregnant women who visited ...

As the cost of living continues to spiral upward, the White House is dismantling the government agency built to protect Americans from financial ruin.

A new analysis of prescription data found that emergency room orders for acetaminophen for pregnant women fell for weeks ...

After nearly a decade of treatment, a Texas woman reached remission through an FDA-approved cellular therapy for chronic lymphocytic leukemia.